ABOUT THIS EPISODE
From science fiction to clinical reality. What happens when cell therapy moves from promise to proof in patients who have run out of options?
This week on Leading Beyond the Lab, Lawrence Rose sat down with Amit Rakhit, Chief Medical Officer at BlueRock Therapeutics, to explore how regenerative medicine, leadership, and culture intersect at the most pivotal stages of biotech development.
A physician by training, Amit has built his career across large pharma and early stage biotech, including experience at Bristol Myers Squibb and Biogen, working on programmes ranging from rare disease to neurodegeneration. He is also a visible advocate for authenticity and inclusion within the life sciences industry.
In this episode, Amit covers:
• How BlueRock Therapeutics is translating the promise of cell therapy into real clinical trials for Parkinson’s disease, and why this moment is so significant for patients who have exhausted existing treatments (01:09)
• What it takes to balance bold scientific vision with realism, credibility, and execution when leading clinical programmes at a pivotal stage (03:29)
• The real differences between CEO and CMO roles, why leadership is not about hierarchy, and how self-awareness shapes long-term career impact (04:58)
• Why authenticity, diversity of thought, and culture consistently separate successful biotechs from those that struggle, more than metrics alone (06:37)
• Lessons from a career spanning programmes such as Plavix and Spinraza at Biogen, and what physician scientists should consider when transitioning into industry roles (12:00)
If you want to understand how science, leadership, and empathy come together to shape medicines that can truly change lives, this is an episode worth your time.
Check out the full conversation and hear directly from one of the industry’s most thoughtful clinical leaders.
Follow ARTO: https://linktr.ee/arto_talent
Amit Rakhit
LinkedIn: https://www.linkedin.com/in/amit-rakhit/
Lawrence Rose
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Introduction and background
01:09 Cell therapy and BlueRock Therapeutics’ mission
03:29 Leadership, credibility, and execution
04:58 CEO vs CMO roles in biotech
06:37 Authenticity, inclusion, and culture
09:24 What separates successful biotechs
12:00 Physician scientists transitioning into industry
18:34 Career-defining moments and resilience
22:38 The future of cell therapy and emerging modalities
24:32 AI in drug discovery and clinical development
26:26 Closing thoughts and where to connect
#LeadingBeyondTheLab #ARTOTalent #CellTherapy #BiotechLeadership #RegenerativeMedicine #LifeSciences #ClinicalDevelopment
Hosted on Acast. See acast.com/privacy for more information.
